FDA Grants Fast Track Designation to Gene Therapy for Hemophilia A Patients – Rare Disease Report
Drug Discovery & Development |
FDA Grants Fast Track Designation to Gene Therapy for Hemophilia A Patients
Rare Disease Report Earlier today, Sangamo Therapeutics, Inc. announced that the U.S. Food and Drug Administration (FDA) granted Fast Track designation to the company’s clinical stage gene therapy candidate for hemophilia A patients – SB-525. Hemophilia A is the effect of … FDA Grants Fast Track Designation to Sangamo’s Hemophilia A Gene TherapyDrug Discovery & Development Novel Hemophilia A Gene Therapy Gets Fast Track StatusMonthly Prescribing Reference (registration) FDA grants fast track designation to SB-525 for hemophilia AHealio PR Newswire (press release) –Schaeffers Research (blog) –CNA Finance (press release) all 81 news articles » |
The Pharma Letter (registration) |
Global Stem Cell Technologies and Applications Market 2017-2027
PR Newswire (press release) The global stem cell technologies and applications market is expected to grow at a CAGR of 13.4% in the first half of the forecast period and CAGR of 10.5% in the second half of the forecast period. The market is expected to grow at a CAGR of 11.7 … Stem cell therapies: can anything stop them now?The Pharma Letter (registration) Global Stem Cell Assay Market – know about Basic Influencing Factors by Manufacturers, Regions, Type and …MilTech Explore stem cell therapy market forecast 2017-2022WhaTech Trade Calls (press release) all 11 news articles » |
Nature.com |
Geneticists enlist engineered virus and CRISPR to battle citrus disease
Nature.com Other projects aim to edit the genome of citrus trees using CRISPR–Cas9 to make them more resistant to the pest, or engineer trees to express defence genes or short RNA molecules that prevent disease transmission. Local growers have also helped to fund … |
Nature.com |
Geneticists enlist engineered virus and CRISPR to battle citrus disease
Nature.com Other projects aim to edit the genome of citrus trees using CRISPR–Cas9 to make them more resistant to the pest, or engineer trees to express defence genes or short RNA molecules that prevent disease transmission. Local growers have also helped to fund … |
Medical Xpress |
Immunotherapy against bee stings in some cases incomplete
Medical Xpress The preparations that are used for allergen immunotherapy against bee sting allergies do not always contain all the relevant venom components. This was the conclusion of an examination conducted by allergy experts at the Helmholtz Zentrum München and … |
|
Immunotherapy against bee stings in some cases incomplete
EurekAlert (press release) This is where allergen-specific immunotherapy, commonly known as allergy shots, can help. The treatment involves injecting very small doses of the venom under the patient’s skin. The idea is to force the body to become accustomed to the poison and … |
Drug Discovery & Development |
FDA Grants Fast Track Designation to Sangamo’s Hemophilia A Gene Therapy
Drug Discovery & Development Sangamo Therapeutics announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to SB-525, the Company’s clinical stage cDNA gene therapy candidate for hemophilia A, which is being developed as part of an … Novel Hemophilia A Gene Therapy Gets Fast Track StatusMonthly Prescribing Reference (registration) FDA grants fast track designation to SB-525 for hemophilia AHealio Sangamo Therapeutics Presents Recent Developments from Research and Clinical Programs at Annual Meeting of the …PR Newswire (press release) Schaeffers Research (blog) –CNA Finance (press release) –Equities.com all 80 news articles » |
Phys.Org |
Researchers uncover new way of growing stem cells
Phys.Org Using hydrogel, a gel with a gradient that can be used to mimic the stiffness of human body tissues, the researchers were able to generate positive outcomes for the growth of stem cells. Dr Yu Suk Choi from UWA’s School of Human Sciences at The … |